Physician Profile
Based in Fort Lauderdale, FL, Matthew B. Zarraga, D.O. is listed in the NPI registry under dermatology. According to Medicare claims data, Matthew cared for 2,224 Medicare patients across 19,277 services. The services billed most often include aminolevulinic acid hcl for topical administration, 10% gel, 10 mg, destruction of precancer skin growth, 2-14 growths, and established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more. NPI 1831327790 identifies this record in the national registry.
Factual summary compiled by Guide.md from public records; not written by this provider.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
2838 E. OAKLAND PARK BOULEVARD S. 201
Fort Lauderdale, FL 33306
Within Dermatology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Acne and follicular disorders
Eczema and inflammatory skin disease
Infections and infestations
Pigment, growths, and benign lesions
Skin cancer
Urticaria, itch, and vascular
Autoimmune and connective tissue
Infections
Rashes & allergy
Skin growths
Most searched procedures
Diagnostic procedures
Lesion treatment
Medical dermatology treatment
Cosmetic
Cosmetic and minor surgery
Cosmetic dermatology
Diagnostic
General dermatology
Infections
Medical dermatology
Nails & hair
Skin cancer surgery
Skin growths
19,277 services · 2,224 patients · 18 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | Procedure | 17003 |
5,591 | More than most peers in Dermatology |
| Destruction of skin growth, 1-14 growths | Procedure | 17110 |
755 | More than most peers in Dermatology |
| Destruction of precancer skin growth, 1 growth | Procedure | 17000 |
736 | More often than most peers in Dermatology |
| Biopsy of related skin growth, first growth | Procedure | 11102 |
210 | More often than most peers in Dermatology |
| Complicated or multiple drainage of skin abscess | Procedure | 10061 |
75 | More than most peers in Dermatology |
| Biopsy of related skin growth, each additional growth | Procedure | 11103 |
66 | As often as other peers in Dermatology |
| Injection into skin growth, 1-7 growths | Procedure | 11900 |
59 | More often than most peers in Dermatology |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Procedure | 17262 |
27 | As often as other peers in Dermatology |
| Punch biopsy, first skin growth | Procedure | 11104 |
15 | Less often than most peers in Dermatology |
| Complicated repair of wound of trunk, 2.6-7.5 cm | Procedure | 13101 |
14 | Less often than most peers in Dermatology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Matthew B. Zarraga is a dermatologist (skin doctor) in Fort Lauderdale, FL. That is the designation recorded for this NPI in the federal registry, where it is listed as “Dermatology”.
NPI registry
Matthew B. Zarraga is listed at 2838 E. Oakland Park Boulevard S. 201, Fort Lauderdale, FL 33306. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (954) 564-0040. Contact the office directly to confirm availability and scheduling.
NPI registry
Matthew B. Zarraga's National Provider Identifier is 1831327790. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Matthew B. Zarraga attended Other, graduating in 2009. This comes from the CMS National Downloadable File.
CMS public data
Matthew B. Zarraga has 17 years experience. Calculated from a graduation year of 2009, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Matthew B. Zarraga performs procedures including destruction of precancer skin growth, 2-14 growths, destruction of skin growth, 1-14 growths and destruction of precancer skin growth, 1 growth; provides treatments such as application of light with debridement to destroy precancer skin growth, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Matthew B. Zarraga. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.